Financials
Financial year 2025
QUALIFY Life Sciences from Brussel, company number BE1004523684, closed financial year 2025 with a result of € 337,721 after tax. For that financial year QUALIFY Life Sciences recorded a gross margin of € 1.5 million and equity of € 404,613. Compared with financial year 2024, the result moved from € 57,893 to € 337,721. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.
€ 404,613
▲ € 337,720 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 337,721
▲ € 279,828 vs 2024
Profit after tax over the fiscal year.
€ 363,181
▲ 167% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 395,613.
People and assets in 2025
€ 984,367
▲ € 859,861 vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 111,577
▲ € 98,634 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 74,543
▼ 31% vs 2024
€ 18,294 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 419,972
▲ € 319,480 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 394,256
▲ € 325,586 vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 203,288 | € 1,489,844 | ▲ € 1.3 million |
| Profit after taxes | € 57,893 | € 337,721 | ▲ € 279,828 |
| Equity | € 66,893 | € 404,613 | ▲ € 337,720 |
| Total debts | € 280,558 | € 891,017 | ▲ 218% |
| Cash | € 136,232 | € 363,181 | ▲ 167% |
| Retained profit | € 57,893 | € 395,613 | ▲ € 337,720 |
| Bank debt | € 108,500 | € 74,543 | ▼ 31% |
| Balance sheet total | € 347,451 | € 1,295,630 | ▲ 273% |
Key figures of QUALIFY Life Sciences, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to QUALIFY Life Sciences?
What happened at QUALIFY Life Sciences in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 337,721 (▲ € 279,828 vs 2024). Source: NBB ↗
- Maud Lombard became a director. NBB
- New establishment in Brussel. KBO
- Dorian De Brabandere became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 57,893 profit in 2024 to € 337,721 profit in 2025.
Paid € 146,898 in corporate taxes since 2024.
Best year ever: 2025, with € 337,721 profit.
A new publication or filing at QUALIFY Life Sciences? We notify you, reason included.
Follow QUALIFY Life SciencesDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind QUALIFY Life Sciences are Dorian De Brabandere and Maud Lombard.
Directors
According to the 2025 annual accounts
Dorian De Brabandere
Director
since 2024
Maud Lombard
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Louizalaan 251
1050 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 8 companies are registered at this address.
All companies at this address →Agrer
€ 7.1 million revenue · 2025
SETESCO Structural Engineers
€ 498,372 gross margin · 2025
Société de Transactions Immobilières et de Constructions
€ 2.3 million revenue · 2025
Comentri
€ 16,789 gross margin · 2025
SOMIBA
€ 463,349 gross margin · 2025
+3 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1004.523.684
- VAT number
- BE 1004.523.684
- Registered office
- Louizalaan 251, 1050 Brussel
- Names & denominations
- QUALIFY Life Sciences · QLS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 January 2024
- Peppol
- Active · Active since 30 Jul 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering